Sigrid Stroobants News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Sigrid stroobants. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Sigrid Stroobants Today - Breaking & Trending Today

Molecular Targeting Technologies, Inc. and University of Antwerp Begin First-in-Human Study of TDURA Diagnostic for Early Detection of Response to Colon Cancer Therapy

Published: May 11, 2021

WEST CHESTER, Pa. (BUSINESS WIRE) Molecular Targeting Technologies, Inc. (MTTI) and University of Antwerp today announced the approval of a Clinical Trial Application by the European Federal Agency for Medicines and Health Products (FAMHP) (equivalent to a US IND). The clinical study will evaluate the safety, dosimetry and treatment response of TDURA (
99mTc-Duramycin), in patients with advanced colorectal cancer (CRC) .
Colorectal cancer is the third most commonly diagnosed malignancy in the world and the second leading cause of cancer death in the United States. While a range of novel active agents has improved the prognosis of patients with colorectal cancer, 50% of advanced colorectal cancer patients die from metastatic disease. ....

United States , Sigrid Stroobants , Chris Pak , Molecular Targeting Technologies Inc , European Federal Agency For Medicines , Nuclear Medicine , National Institutes Of Health , University Of Antwerp , Health Products , Targeting Technologies , Clinical Trial Application , European Federal Agency , National Institutes , National Cancer Institute , ஒன்றுபட்டது மாநிலங்களில் , கிறிஸ் பக் , அணு மருந்து , தேசிய நிறுவனங்கள் ஆஃப் ஆரோக்கியம் , பல்கலைக்கழகம் ஆஃப் ஆண்ட்வெர்ப் , ஆரோக்கியம் ப்ராடக்ட்ஸ் , மருத்துவ சோதனை விண்ணப்பம் , தேசிய நிறுவனங்கள் , தேசிய புற்றுநோய் நிறுவனம் ,